Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 3 for:    Gracell
Previous Study | Return to List | Next Study

A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03825731
Recruitment Status : Recruiting
First Posted : January 31, 2019
Last Update Posted : January 31, 2019
Sponsor:
Collaborator:
Gracell Biotechnology Ltd.
Information provided by (Responsible Party):
Hebei Yanda Ludaopei Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 16, 2019
  Estimated Study Completion Date : September 16, 2019